Girón AE, Velasco FR, Sánchez LR, Martínez BK

Language: Spanish
References: 15
Page: 149-153
PDF size: 102.26 Kb.

ABSTRACT

Objective: To evaluate the clinical and functional efficacy of triamcinolone acetonide versus mometasone furoate in the treatment of non-allergic rhinopathy.
Patients and method: In a prospective study, done at a tertiary care center, 20 patients were included and assigned to one of two groups of 10 patients each. A clinical evaluation was done and analogue visual scale, the mini-RQLQ and the saccharin test were applied. Group A was given triamcinolone acetonide (220 µg/d) for 30 days, and group B received mometasone furoate (200 µg/d) also for 30 days. Functional clinical improvement, safety and efficacy of both treatments of non-allergic rhinopathy were assessed.
Results: There was an improvement demonstrated by the decreased scores on the analog visual scale and the mini-RQLQ. Mucociliary function was favored with 30 days of treatment with triamcinolone acetonide (p ‹ 0.05). In patients treated with mometasone furoate incidence of minor adverse reactions was higher.
Conclusions: In the treatment of allergic rhinopathy the effect of the triamcinolone acetonide is better than with mometasone furoate. Both drugs are safe.

REFERENCES

1. Wallace DV, Dykewicz MS, Bernstein DI, Blessing MJ, et al. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol 2008;122(2 Suppl):S1-84.

2. Baraniuk JN. Pathogenic mechanisms of idiopatic nonallergic rhinitis. World Allergy Organiz J 2009;2:106-114.

3. Kaliner MA. Classification of nonallergic rhinitis syndromes with a focus on vasomotor rhinitis, proposed to be known henceforth as nonallergic rhinopathy. World Allergy Organiz J 2009;2:98-101.

4. Settipane RA, Lieberman P. Update on nonallergic rhinitis. Ann Allergy Asthma Immunol 2001;86:494-507.

5. Settipane RA. Epidemiology of vasomotor rhinitis. World Allergy Organiz J 2009;2:115-118.

6. Nielsen LP, Dahl R. Comparison of intranasal corticosteroids and antihistamines in allergic rhinitis: a review of randomized, controlled trials. Am J Respir Med 2003;2:55-65.

7. Synnerstad B, Lindqvist N. A clinical comparison of intranasal budesonide with beclomethasone dipropionate for perennial non-allergic rhinitis: a 12 month study. Br J Clin Pract 1996;50(7):363-366.

8. Adamopoulos G, Manolopoulos L, Giotakis I. A comparison of the efficacy and patient acceptability of budesonide and beclomethasone dipropionate aqueous nasal sprays in patients with perennial rhinitis. Clin Otolaryngol Allied Sci 1995;20(4):340-344.

9. Scadding GK, Lund VJ, Jacques LA, Richards DH. A placebo-controlled study of fluticasone propionate aqueous nasal spray and beclomethasone dipropionate in perennial rhinitis: efficacy in allergic and non-allergic perennial rhinitis. Clin Exp Allergy 1995;25(8):737-743.

10. Mandl M, Nolop K, Lutsky BN. Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. 194-079 Study Group. Ann Allergy Asthma Immunol 1997;79(4):370-378.

11. Drouin M, Yang WH, Bertrand B, Van Cauwenberge P, et al. Once daily mometasone furoate aqueous nasal spray is as effective as twice daily beclomethasone dipropionate for treating perennial allergic rhinitis patients. Ann Allergy Asthma Immunol 1996;77(2):153-160.

12. Naclerio RM, Baroody FM, Bidani N, De Tineo M, Penney BC. A comparison of nasal clearance after treatment of perennial allergic rhinitis with budesonide and mometasone. Otolaryngol Head Neck Surg 2003;128:220-227.

13. Plaza VP, Carrión F, Marín J, Bautista D y col. Test de la sacarina en el estudio del aclaramiento mucociliar: valores de referencia en una población española. Arch Bronconeumol 2008;44(10):540-545.

14. Joki S, Saano V, Nuutinen J, Virta P, et al. Effects of some preservative agents on rat and guinea pig tracheal and human nasal ciliary beat frequency. Am J Rhinology 1996;10:181-186.

15. Steinsvag SK, Bjerknes R, Berg OH. Effects of topical nasal steroids on human respiratory mucosa and human granulocytes in vitro. Acta Otolaryngol 1996;116:868-875.